Tight junction-related human diseases

Pathology International

Volumn 63, Issue 1, 2013, Pages 1-12

  Sawada, Norimasa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Barrier function; Cancer; Claudin; Fence function; Human diseases; Immunity; Occludin; Tight junctions

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CALCIUM ION; CLAUDIN; CYTOPLASM PROTEIN; JUNCTIONAL ADHESION MOLECULE A; JUNCTIONAL ADHESION MOLECULE B; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MEMBRANE PROTEIN; MERLIN; OCCLUDIN; STROMELYSIN; THYMIC STROMAL LYMPHOPOIETIN; TIGHT JUNCTION PROTEIN; TRICELLULIN; UVOMORULIN;

ACTIN FILAMENT; ALLERGIC RHINITIS; ASTHMA; BACTERIAL INFECTION; BLOOD BRAIN BARRIER; CELIAC DISEASE; CELL ADHESION; CELL COMMUNICATION; CELL POLARITY; CELL PROLIFERATION; COLLAGENOUS COLITIS; CROHN DISEASE; DENDRITIC CELL; DIABETIC RETINOPATHY; DIAPEDESIS; DISTRESS SYNDROME; EDEMA; ENDOTOXEMIA; GASTRITIS; GENE MUTATION; GENETIC DISORDER; GROWTH INHIBITION; HEPATITIS C; HUMAN; HYPOMAGNESEMIA; INNATE IMMUNITY; JAUNDICE; MALABSORPTION; NEOPLASM; NONHUMAN; NOSE ALLERGY; PATHOGENESIS; POLARIZATION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RESPIRATORY DISTRESS SYNDROME; REVIEW; SCLEROSING CHOLANGITIS; SIGNAL TRANSDUCTION; TIGHT JUNCTION; ULCERATIVE COLITIS; VACCINATION; VIRUS INFECTION; VITAMIN D DEFICIENCY;

CELLULAR MICROENVIRONMENT; CLAUDINS; HUMANS; IMMUNITY, INNATE; NEOPLASMS; OCCLUDIN; SIGNAL TRANSDUCTION; TIGHT JUNCTION PROTEINS; TIGHT JUNCTIONS;

EID: 84873088762     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12021     Document Type: Review

References (119)

1. Schneeberger EE, Lynch RD. The tight junction: A multifunctional complex. Am J Physiol Cell Physiol 2004; 286: C1213-1228.
2. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2: 285-293.
3. Tsukita S, Furuse M. Claudin-based barrier in simple and stratified cellular sheets. Curr Opin Cell Biol 2002; 14: 531-536.
4. Tsukita S, Yamazaki Y, Katsuno T, Tamura A, Tsukita S. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 2008; 27: 6930-6938.
5. Schulzke JD, Günzel D, John LJ, Fromm M. Perspectives on tight junction research. Ann N Y Acad Sci 2012; 1257: 1-19.
6. Sawada N, Murata M, Kikuchi K etal. Tight junctions and human diseases. Med Electron Microsc 2003; 36: 147-156.
7. Mineta K, Yamamoto Y, Yamazaki Y etal. Predicted expansion of the claudin multigene family. FEBS Lett 2011; 585: 606-612.
8. Raleigh DR, Marchiando AM, Zhang Y etal. Tight junction-associated MARVEL proteins marvelD3, tricellulin, and occludin have distinct but overlapping functions. Mol Biol Cell 2010; 21: 1200-1213.
9. Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 2005; 171: 939-945.
10. Osler ME, Chang MS, Bader DM. Bves modulates epithelial integrity through an interaction at the tight junction. J Cell Sci 2005; 118: 4667-4678.
11. Masuda S, Oda Y, Sasaki H etal. LSR defines cell corners for tricellular tight junction formation in epithelial cells. J Cell Sci 2011; 124: 548-555.
12. Furuse M, Sasaki H, Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 1999; 147: 891-903.
13. Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Annu Rev Physiol 2006; 68: 403-429.
14. Hadj-Rabia S, Baala L, Vabres P etal. Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: A tight junction disease. Gastroenterology 2004; 127: 1386-1390.
15. Wilcox ER, Burton QL, Naz S etal. Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell 2001; 104: 165-172.
16. Tsukita S, Furuse M. Pores in the wall: Claudins constitute tight junction strands containing aqueous pores. J Cell Biol 2000; 149: 13-16.
17. Colegio OR, Van Itallie CM, McCrea HJ, Rahner C, Anderson JM. Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am J Physiol Cell Physiol 2002; 283: C142-147.
18. 2+ resorption. Science 1999; 285: 103-106.
19. Konrad M, Schaller A, Seelow D etal. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 2006; 79: 949-957.
20. Zeisel MB, Fofana I, Fafi-Kremer S, Baumert TF. Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies. J Hepatol 2011; 54: 566-576.
21. Miyamori H, Takino T, Kobayashi Y etal. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J Biol Chem 2001; 276: 28204-28211.
22. Leotlela PD, Wade MS, Duray PH etal. Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene 2007; 26: 3846-3856.
23. Ding L, Lu Z, Foreman O etal. Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice. Gastroenterology 2012; 142: 305-315.
24. Ladwein M, Pape UF, Schmidt DS etal. The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7. Exp Cell Res 2005; 309: 345-357.
25. Furuse M, Hirase T, Itoh M etal. Occludin: A novel integral membrane protein localizing at tight junctions. J Cell Biol 1993; 123: 1777-1788.
26. Saitou M, Fujimoto K, Doi Y etal. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol 1998; 141: 397-408.
27. Saitou M, Ando-Akatsuka Y, Itoh M etal. Mammalian occludin in epithelial cells: Its expression and subcellular distribution. Eur J Cell Biol 1997; 73: 222-231.
28. Tsukita S, Furuse M. Occludin and claudins in tight-junction strands: Leading or supporting players? Trends Cell Biol 1999; 9: 268-273.
29. Cummins PM. Occludin: One protein, many forms. Mol Cell Biol 2012; 32: 242-250.
30. Murata M, Kojima T, Yamamoto T etal. Down-regulation of survival signaling through MAPK and Akt in occludin-deficient mouse hepatocytes in vitro. Exp Cell Res 2005; 310: 140-151.
31. Osanai M, Murata M, Nishikiori N, Chiba H, Kojima T, Sawada N. Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes. Cancer Res 2006; 66: 9125-9133.
32. Kojima T, Fuchimoto J, Yamaguchi H etal. c-Jun N-terminal kinase is largely involved in the regulation of tricellular tight junctions via tricellulin in human pancreatic duct epithelial cells. J Cell Physiol 2010; 225: 720-733.
33. Riazuddin S, Ahmed ZM, Fanning AS etal. Tricellulin is a tight-junction protein necessary for hearing. Am J Hum Genet 2006; 79: 1040-1051.
34. Chiba H, Osanai M, Murata M, Kojima T, Sawada N. Transmembrane proteins of tight junctions. Biochim Biophys Acta 2008; 1778: 588-600.
35. 2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 2002; 3: 151-158.
36. Barton ES, Forrest JC, Connolly JL etal. Junction adhesion molecule is a receptor for reovirus. Cell 2001; 104: 441-451.
37. Weber C, Fraemohs L, Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 2007; 7: 467-477.
38. Sugihara-Mizuno Y, Adachi M, Kobayashi Y etal. Molecular characterization of angiomotin/JEAP family proteins: Interaction with MUPP1/Patj and their endogenous properties. Genes Cells 2007; 12: 473-486.
39. Umeda K, Ikenouchi J, Katahira-Tayama S etal. ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell 2006; 126: 741-754.
40. Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011; 13: 877-883.
41. Yi C, Troutman S, Fera D etal. A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions. Cancer Cell 2011; 19: 527-540.
42. Suzuki A, Ohno S. The PAR-aPKC system: Lessons in polarity. J Cell Sci 2006; 119: 979-987.
43. Chiba H, Gotoh T, Kojima T etal. Hepatocyte nuclear factor (HNF)-4α triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells. Exp Cell Res 2003; 286: 288-297.
44. Satohisa S, Chiba H, Osanai M etal. Behavior of tight-junction, adherens-junction and cell polarity proteins during HNF-4α-induced epithelial polarization. Exp Cell Res 2005; 310: 66-78.
45. Chiba H, Sakai N, Murata M etal. The nuclear receptor hepatocyte nuclear factor 4α acts as a morphogen to induce the formation of microvilli. J Cell Biol 2006; 175: 971-980.
46. Muckter H, Ben-Shaul Y, Bacher A. ATP requirement for induced tight junction formation in HT 29 adenocarcinoma cells. Eur J Cell Biol 1987; 44: 258-264.
47. Rodgers LS, Fanning AS. Regulation of epithelial permeability by the actin cytoskeleton. Cytoskeleton 2011; 68: 653-660.
48. Mandel LJ, Bacallao R, Zampighi G. Uncoupling of the molecular 'fence' and paracellular 'gate' functions in epithelial tight junctions. Nature 1993; 361: 552-555.
49. Takakuwa R, Kokai Y, Kojima T etal. Uncoupling of gate and fence functions of MDCK cells by the actin-depolymerizing reagent mycalolide B. Exp Cell Res 2000; 257: 238-244.
50. Kojima T, Murata M, Go M, Spray DC, Sawada N. Connexins induce and maintain tight junctions in epithelial cells. J Membr Biol 2007; 217: 13-19.
51. Vermeer PD, Einwalter LA, Moninger TO etal. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature 2003; 422: 322-326.
52. Balda MS, Matter K. Tight junctions and the regulation of gene expression. Biochim Biophys Acta 2009; 1788: 61-67.
53. Barrios-Rodiles M, Brown KR, Ozdamar B etal. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 2005; 307: 1621-1625.
54. Li W, Cooper J, Karajannis MA, Giancotti FG. Merlin: A tumour suppressor with functions at the cell cortex and in the nucleus. EMBO Rep 2012; 13: 204-215.
55. Rescigno M, Urbano M, Valzasina B etal. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2: 361-367.
56. Takano K, Kojima T, Go M etal. HLA-DR- and CD11c-positive dendritic cells penetrate beyond well-developed epithelial tight junctions in human nasal mucosa of allergic rhinitis. J Histochem Cytochem 2005; 53: 611-619.
57. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 2009; 206: 2937-2946.
58. Kamekura R, Kojima T, Koizumi J etal. Thymic stromal lymphopoietin enhances tight-junction barrier function of human nasal epithelial cells. Cell Tissue Res 2009; 338: 283-293.
59. Kamekura R, Kojima T, Takashima A etal. Thymic stromal lymphopoietin induces tight junction protein claudin-7 via NF-κB in dendritic cells. Histochem Cell Biol 2010; 133: 339-348.
60. Ohkuni T, Kojima T, Ogasawara N etal. Poly(I:C) reduces expression of JAM-A and induces secretion of IL-8 and TNF-α via distinct NF-κB pathways in human nasal epithelial cells. Toxicol Appl Pharmacol 2011; 250: 29-38.
61. Yuki T, Yoshida H, Akazawa Y, Komiya A, Sugiyama Y, Inoue S. Activation of TLR2 enhances tight junction barrier in epidermal keratinocytes. J Immunol 2011; 187: 3230-3237.
62. Cera MR, Fabbri M, Molendini C etal. JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recycling. J Cell Sci 2009; 122 (Pt 2): 268-277.
63. Alexander JS, Dayton T, Davis C etal. Activated T-lymphocytes express occludin, a component of tight junctions. Inflammation 1998; 22: 573-582.
64. Huber D, Balda MS, Matter K. Occludin modulates transepithelial migration of neutrophils. J Biol Chem 2000; 275: 5773-5778.
65. Edelblum KL, Shen L, Weber CR etal. Dynamic migration of γδ intraepithelial lymphocytes requires occludin. Proc Natl Acad Sci U S A 2012; 109: 7097-7102.
66. Kawai Y, Hamazaki Y, Fujita H etal. Claudin-4 induction by E-protein activity in later stages of CD4/8 double-positive thymocytes to increase positive selection efficiency. Proc Natl Acad Sci U S A 2011; 108: 4075-4080.
67. Katahira J, Sugiyama H, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem 1997; 272: 26652-26658.
68. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tsukita S. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 2000; 476: 258-261.
69. Sonoda N, Furuse M, Sasaki H etal. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 1999; 147: 195-204.
70. Maeda T, Murata M, Chiba H etal. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer. Prostate 2012; 72: 351-360.
71. Saadat I, Higashi H, Obuse C etal. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007; 447: 330-333.
72. Suzuki K, Kokai Y, Sawada N etal. SS1 Helicobacter pylori disrupts the paracellular barrier of the gastric mucosa and leads to neutrophilic gastritis in mice. Virchows Arch 2002; 440: 318-324.
73. Wu Z, Nybom P, Magnusson KE. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell Microbiol 2000; 2: 11-17.
74. Javier RT, Rice AP. Emerging theme: Cellular PDZ proteins as common targets of pathogenic viruses. J Virol 2011; 85: 11544-11556.
75. Bronner F, Slepchenko B, Wood RJ, Pansu D. The role of passive transport in calcium absorption. J Nutr 2003; 133: 1426.
76. Hoenderop JG, Nilius R, Bindels RJ. Calcium absorption across epithelia. Physiol Rev 2005; 85: 373-422.
77. Fujita H, Chiba H, Yokozaki H etal. Differential expression and subcellular localization of claudin-7, -8, -12, -13, and -15 along the mouse intestine. J Histochem Cytochem 2006; 54: 933-944.
78. 2+ absorption between enterocytes. Mol Biol Cell 2008; 19: 1912-1921.
79. Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 2001; 24: 719-725.
80. Igarashi Y, Utsumi H, Chiba H etal. Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. Biochem Biophys Res Commun 1999; 261: 108-112.
81. Utsumi H, Chiba H, Kamimura Y etal. Expression of GFRα-1, receptor for GDNF, in rat brain capillary during postnatal development of the BBB. Am J Physiol Cell Physiol 2000; 279: C361-368.
82. Igarashi Y, Chiba H, Utsumi H etal. Expression of receptors for glial cell line-derived neurotrophic factor (GDNF) and neurturin in the inner blood-retinal barrier of rats. Cell Struct Funct 2000; 25: 237-241.
83. Kamimura Y, Chiba H, Utsumi H, Gotoh T, Tobioka H, Sawada N. Barrier function of microvessels and roles of glial cell line-derived neurotrophic factor in the rat testis. Med Electron Microsc 2002; 35: 139-145.
84. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993; 260: 1130-1132.
85. Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K. The temporal and spatial vascular endothelial growth factor expression in retinal vasculogenesis of rat neonates. Lab Invest 1996; 74: 68-77.
86. Miyajima H, Osanai M, Chiba H etal. Glyceraldehyde-derived advanced glycation end-products preferentially induce VEGF expression and reduce GDNF expression in human astrocytes. Biochem Biophys Res Commun 2005; 330: 361-366.
87. Nishikiori N, Osanai M, Chiba H etal. Glial cell-derived cytokines attenuate the breakdown of vascular integrity in diabetic retinopathy. Diabetes 2007; 56: 1333-1340.
88. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9: 799-809.
89. Groschwitz KR, Hogan SP. Intestinal barrier function: Molecular regulation and disease pathogenesis. J Allergy Clin Immunol 2009; 24: 3-20.
90. Kojima T, Murata M, Yamamoto T etal. Tight junction proteins and signal transduction pathways in hepatocytes. Histol Histopathol 2009; 24: 1463-1672.
91. Soini Y. Claudins in lung diseases. Respir Res 2011; 12: 70.
92. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007; 120: 1233-1244.
93. Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic disease. J Cli Invest 2012; 122: 440-447.
94. Ashida H, Ogawa M, Kim M, Mimuro H, Sasakawa C. Bacterial and host interactions in the gut epithelial barrier. Nat Chem Biol 2011; 8: 36-45.
95. Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 1999; 274: 23463-23467.
96. Wang W, Dentler WL, Borchardt RT. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol 2001; 280: H434-440.
97. Tobioka H, Isomura H, Kokai Y, Sawada N. Polarized distribution of carcinoembryonic antigen is associated with a tight junction molecule in human colorectal adenocarcinoma. J Pathol 2002; 198: 207-212.
98. Tobioka H, Isomura H, Kokai Y, Tokunaga Y, Yamaguchi J, Sawada N. Occludin expression decreases with the progression of human endometrial carcinoma. Hum Pathol 2004; 35: 159-164.
99. Moreno-Bueno G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008; 27: 6958-6969.
100. Floor S, van Staveren WC, Larsimont D, Dumont JE, Maenhaut C. Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: Distinct, overlapping or same populations. Oncogene 2011; 30: 4609-4621.
101. Ikenouchi J, Matsuda M, Furuse M, Tsukita S. Regulation of tight junctions during the epithelium-mesenchyme transition: Direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 2003; 116: 1959-1967.
102. Kojima T, Takasawa A, Kyuno D etal. Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells. Exp Cell Res 2011; 317: 2288-2298.
103. Singh AB, Sharma A, Dhawan P. Claudin family of proteins and cancer: An overview. J Oncol 2010; 2010: 541957.
104. Kominsky SL, Argani P, Korz D etal. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003; 22: 2021-2033.
105. Honda H, Pazin MJ, Ji H, Wernyj RP, Morin PJ. Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. J Biol Chem 2006; 281: 21433-21444.
106. Sahin U, Koslowski M, Dhaene K etal. Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development. Clin Cancer Res 2008; 14: 7624-7634.
107. Satoh H, Zhong Y, Isomura H etal. Localization of 7H6 tight junction-associated antigen along the cell border of vascular endothelial cells correlates with paracellular barrier function against ions, large molecules, and cancer cells. Exp Cell Res 1996; 222: 269-274.
108. Tobioka H, Sawada N, Zhong Y, Mori M. Enhanced paracellular barrier function of rat mesothelial cells partially protects against cancer cell penetration. Br J Cancer 1996; 74: 439-445.
109. Miller G. Breaking down the barriers. Science 2002; 297: 1116-1118.
110. Fasano A, Uzzau S. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J Clin Invest 1997; 99: 1158-1164.
111. Matsuhisa K, Kondoh M, Suzuki H, Yagi K. Comparison of mucosal absorption-enhancing activity between a claudin-3/-4 binder and a broadly specific claudin binder. Biochem Biophys Res Commun 2012; 423: 229-333.
112. Ogasawara N, Kojima T, Go M etal. Epithelial barrier and antigen uptake in lymphoepithelium of human adenoids. Acta Otolaryngol 2011; 131: 116-123.
113. Shinozaki A, Shibahara J, Noda N etal. Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma. Virchows Arch 2011; 459: 73-80.
114. Karanjawala ZE, Illei PB, Ashfaq R etal. New markers of pancreatic cancer identified through differential gene expression analysis: Claudin-18 and annexin A8. Am J Pathol 2008; 32: 188-196.
115. Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ. Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer 2009; 9: 244.
116. Michl P, Buchholz M, Rolke M etal. Claudin-4: A new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 2001; 121: 678-684.
117. Yamaguchi H, Kojima T, Ito T etal. Effects of Clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cells. Cell Mol Biol Lett 2011; 16: 385-397.
118. Suzuki H, Kondoh M, Kakutani H etal. The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice. Biomaterials 2012; 33: 317-324.
119. Matsuhisa K, Kondoh M, Suzuki H, Yagi K. Comparison of mucosal absorption-enhancing activity between a claudin-3/-4 binder and a broadly specific claudin binder. Biochem Biophys Res Commun 2012; 423: 229-233.